Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

被引:0
|
作者
Basli, Abdelkader [1 ,2 ]
Bounaas, Jihane [1 ]
机构
[1] Univ Skikda, Fac Sci, Lab Interact Res Biodivers Ecosyst & Biotech, Skikda, Algeria
[2] Univ August 20 1955, 1955 BP 26,Rd El Hadaiek, Skikda 21000, Algeria
关键词
Alzheimer's disease; amyloid beta; tau protein; novel therapies; AMYLOID-BETA-PEPTIDE; APOLIPOPROTEIN-E; TAU-PROTEIN; NITRIC-OXIDE; POSTTRANSLATIONAL MODIFICATIONS; GAMMA-SECRETASE; PHOSPHORYLATION; PEROXYNITRITE; AGGREGATION; INHIBITION;
D O I
10.1177/02601060221137104
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Alzheimer's disease (AD) is characterized by the presence of two types of protein deposits in the brain, amyloid plaques and neurofibrillary tangles. The first one are dense deposits of beta amyloid protein, the second one are dense deposits of the protein tau. These proteins are present in all of our brains, but in AD they act unusually, leading to neuronal degeneration. This review will provide an overview of the AD, including the role of amyloid beta and tau, and mechanisms that lead to the formation of plaques and tangles. The review will also cover the existing researches that have focused on the inhibition of amyloid beta formation, cholinesterase, tau hyperphosphorylation, the pathogenic mechanisms of apoE4, and GSK-3 as a solution that could be used to slow or prevent the disease.
引用
收藏
页码:403 / 413
页数:11
相关论文
共 50 条
  • [31] Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism
    Jiwei Jiang
    Hanping Shi
    Shirui Jiang
    Anxin Wang
    Xinying Zou
    Yanli Wang
    Wenyi Li
    Yuan Zhang
    Mengfan Sun
    Qiwei Ren
    Jun Xu
    Science China Life Sciences, 2023, 66 : 2257 - 2279
  • [32] A review of autophagy mechanism of statins in the potential therapy of Alzheimer's disease
    Liu, Lu
    Dai, Wen-Zhuo
    Zhu, Xi-Chen
    Ma, Tao
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2022, 21 (02)
  • [33] Recent advances in the therapeutic development for Alzheimer's disease
    Gao, Xinyi
    Zhang, Juan
    Liu, Qiang
    CHINESE SCIENCE BULLETIN-CHINESE, 2024, 69 (17): : 2351 - 2359
  • [34] Misfolded proteins as a therapeutic target in Alzheimer's disease
    Liyanage, S. Imindu
    Weaver, Donald F.
    PROTEIN MISFOLDING, 2020, 118 : 371 - 411
  • [35] AMPK: Potential Therapeutic Target for Alzheimer's Disease
    Yang, Luping
    Jiang, Yijing
    Shi, Lihong
    Zhong, Dongling
    Li, Yuxi
    Li, Juan
    Jin, Rongjiang
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2020, 21 (01) : 66 - 77
  • [36] Current therapeutic targets for the treatment of Alzheimer's disease
    Grill, Joshua D.
    Cummings, Jeffrey L.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (05) : 711 - 728
  • [37] Therapeutic implications of glycogen synthase kinase-3β in Alzheimer's disease: a novel therapeutic target
    Mandlik, Deepa S.
    Mandlik, Satish K.
    Arulmozhi, S.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (06) : 603 - 619
  • [38] Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
    Folch, Jaume
    Petrov, Dmitry
    Ettcheto, Miren
    Abad, Sonia
    Sanchez-Lopez, Elena
    Luisa Garcia, M.
    Olloquequi, Jordi
    Beas-Zarate, Carlos
    Auladell, Carme
    Camins, Antoni
    NEURAL PLASTICITY, 2016, 2016
  • [39] Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease?
    Lo Vecchio, Filomena
    Bisceglia, Paola
    Imbimbo, Bruno Pietro
    Lozupone, Madia
    Latino, Raffaela Rita
    Resta, Emanuela
    Leone, Maurizio
    Solfrizzi, Vincenzo
    Greco, Antonio
    Daniele, Antonio
    Watling, Mark
    Panza, Francesco
    Seripa, Davide
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [40] Multitarget therapeutic strategies for Alzheimer's disease
    Ibrahim, Mostafa M.
    Gabr, Moustafa T.
    NEURAL REGENERATION RESEARCH, 2019, 14 (03) : 437 - 440